Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16255)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 7, 2016 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Niu ZS, Niu XJ, Wang WH. Genetic alterations in hepatocellular carcinoma: An update. World J Gastroenterol 2016; 22(41): 9069-9095 [PMID: 27895396 DOI: 10.3748/wjg.v22.i41.9069] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i41/9069.htm |
| Number | Citing Articles |
| 1 |
Zhun Xiao, Fangming Yang, Zheng Liu, Xinju Chen, Suping Ma, Heng Li. An overview of risk assessment and monitoring of malignant transformation in cirrhotic nodules. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241293019
|
| 2 |
Qicong Mai, Dafeng Sheng, Chengcong Chen, Qing Gou, Meng Chen, Xiaoting Huang, Heng Yin, Xiaoming Chen, Zide Chen. Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC). Aging 2020; 12(24): 25395 doi: 10.18632/aging.104142
|
| 3 |
Saad Saffo, Tamar H. Taddei. Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies. Digestive Diseases and Sciences 2019; 64(4): 1016 doi: 10.1007/s10620-019-05582-x
|
| 4 |
Ting Lei, Xiaodong Zhu, Kai Zhu, Fuxin Jia, Siqiao Li. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Cancer Biology & Therapy 2019; 20(7): 1007 doi: 10.1080/15384047.2019.1595276
|
| 5 |
Germana Castelli, Elvira Pelosi, Ugo Testa. Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. Cancers 2017; 9(9): 127 doi: 10.3390/cancers9090127
|
| 6 |
Mazen Hassanain, Yang Liu, Weam Hussain, Albandri Binowayn, Duna Barakeh, Ebtehal Alsolme, Faisal AlSaif, Ghaida Almasaad, Mohammed AlSwayyed, Maram Alaqel, Rana Aljunidel, Sherin Abdelrahman, Charlotte A. E. Hauser, Saleh Alqahtani, Robert Hoehndorf, Malak Abedalthagafi. Genomic landscape in Saudi patients with hepatocellular carcinoma using whole-genome sequencing: a pilot study. Frontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1205415
|
| 7 |
Ji‐Chang Fan, Fei Zeng, Yi‐Guan Le, Lin Xin. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR‐24‐3p. Journal of Cellular Biochemistry 2018; 119(8): 6391 doi: 10.1002/jcb.26479
|
| 8 |
L.S.S. Srivani Nagam, Ramakrishna Vadde, Rajeswari Jinka. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 125 doi: 10.1016/B978-0-323-98806-3.00013-1
|
| 9 |
Luis Cano, Stéphane Bertani, Marie-Laure Island, Juan Pablo Cerapio, Eloy Ruiz, Pascal Pineau, Valérie Monbet, Karim Boudjema, Luis Taxa, Sandro Casavilca-Zambrano, Martine Ropert, Bruno Turlin, Olivier Loréal. Metallomic profile in non-cirrhotic hepatocellular carcinoma supports a phenomenon of metal metabolism adaptation in tumor cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93369-4
|
| 10 |
María Gárate-Rascón, Miriam Recalde, Carla Rojo, Maite G. Fernández-Barrena, Matías A. Ávila, María Arechederra, Carmen Berasain. SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and Disease. International Journal of Molecular Sciences 2022; 23(21): 13411 doi: 10.3390/ijms232113411
|
| 11 |
Ayoob D Abdullah, Hayder J. Taher, Hayder S. Alareer, Ahmed M. Easa, Hussein A. Dakhil, Raad A. Bustan. The Different MRI Features of Hepatocellular Adenoma and Hepatocellular Carcinoma. Journal of Pharmacy and Bioallied Sciences 2023; 15(Suppl 2): S1046 doi: 10.4103/jpbs.jpbs_230_23
|
| 12 |
|
| 13 |
Bárbara Ferreira, Adrián Heredia, Jacinta Serpa. An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC). Molecular and Cellular Endocrinology 2023; 578: 112063 doi: 10.1016/j.mce.2023.112063
|
| 14 |
Max J. Carlsson, Anastasia S. Vollmer, Philipp Demuth, Daniel Heylmann, Diana Reich, Caroline Quarz, Birgit Rasenberger, Teodora Nikolova, Thomas G. Hofmann, Markus Christmann, Julia A. Fuhlbrueck, Simone Stegmüller, Elke Richling, Alexander T. Cartus, Jörg Fahrer. p53 triggers mitochondrial apoptosis following DNA damage-dependent replication stress by the hepatotoxin methyleugenol. Cell Death & Disease 2022; 13(11) doi: 10.1038/s41419-022-05446-9
|
| 15 |
Miguel Sogbe, Idoia Bilbao, Francesco P. Marchese, Jon Zazpe, Annarosaria De Vito, Marta Pozuelo, Delia D’Avola, Mercedes Iñarrairaegui, Carmen Berasain, Maria Arechederra, Josepmaria Argemi, Bruno Sangro. Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment. Clinical and Molecular Hepatology 2024; 30(2): 177 doi: 10.3350/cmh.2023.0426
|
| 16 |
Liang Zhang, Yi Huang, Yi Zhu, Zhen Yu, Mengmeng Shao, Yunbo Luo. Identification and Characterization of Cadmium-Related Genes in Liver Carcinoma. Biological Trace Element Research 2018; 182(2): 238 doi: 10.1007/s12011-017-1106-z
|
| 17 |
Xia Chen, Ling Liao, Yuwei Li, Hengliu Huang, Qing Huang, Shaoli Deng. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7653506
|
| 18 |
Karthikeyan Murugesan, Radwa Sharaf, Meagan Montesion, Jay A. Moore, James Pao, Dean C. Pavlick, Garrett M. Frampton, Vivek A. Upadhyay, Brian M. Alexander, Vincent A. Miller, Milind M. Javle, Tanios S. Bekaii Saab, Lee A. Albacker, Jeffrey S. Ross, Siraj M. Ali. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma. JCO Precision Oncology 2021; (5): 1285 doi: 10.1200/PO.20.00397
|
| 19 |
Aaron Koenig, Juan Barajas, María Guerrero, Kalpana Ghoshal. A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(3): 851 doi: 10.3390/ijms19030851
|
| 20 |
Xuejing Zhang, Hongling Li, Mingfeng Mao, Xiangyang Wang, Jingjing Zheng, Shunshi Yang. Mitotically‑associated long non‑coding RNA promotes cancer cell proliferation in hepatocellular carcinoma by downregulating miR‑122a. Oncology Letters 2019; doi: 10.3892/ol.2019.10947
|
| 21 |
Haoming Lin, Rui Zhang, Wenrui Wu, Liming Lei. Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma. Cancer Genetics 2020; 245: 27 doi: 10.1016/j.cancergen.2020.04.076
|
| 22 |
Nehmé Saksouk, Shefqet Hajdari, Yannick Perez, Marine Pratlong, Célia Barrachina, Céline Graber, Damien Grégoire, Aliki Zavoriti, Amélie Sarrazin, Nelly Pirot, Jean-Yohan Noël, Lakhdar Khellaf, Eric Fabbrizio, Eric Julien, Florence M. Cammas. The mouse HP1 proteins are essential for preventing liver tumorigenesis. Oncogene 2020; 39(13): 2676 doi: 10.1038/s41388-020-1177-8
|
| 23 |
Shimaa Abdelsattar, Sally A. Fahim, Hala F. M. Kamel, Hiba Al-Amodi, Zeinab A. Kasemy, Fatma O. Khalil, Mahmoud S. Abdallah, Hanan M. Bedair, Abdel-Naser Abdel-Atty Gadallah, Aliaa Sabry, Mohamed A. Sakr, Mahmoud Selim, Eman M. Abd El Gayed. The Potential Role of Circulating Long Miscellaneous RNAs in the Diagnosis and Prognosis of Hepatitis C Related Hepatocellular Carcinoma. Non-Coding RNA 2023; 9(5): 62 doi: 10.3390/ncrna9050062
|
| 24 |
Seung-Hun Kim, Wen-Hsing Wang, Jing-Ping Wang, Chang-Heng Hsieh, Kang Fang. Teroxirone suppresses growth and motility of human hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy 2018; 99: 997 doi: 10.1016/j.biopha.2018.01.157
|
| 25 |
Nirmala Subramaniam, Pugazhendhi Kannan, Ashokkumar K, Devaki Thiruvengadam. Hepatoprotective effect of boldine against diethylnitrosamine‐induced hepatocarcinogenesis in wistar rats. Journal of Biochemical and Molecular Toxicology 2019; 33(12) doi: 10.1002/jbt.22404
|
| 26 |
Zhenggang Wu, Xi Long, Shui Ying Tsang, Taobo Hu, Jian-Feng Yang, Wai Kin Mat, Hongyang Wang, Hong Xue. Genomic subtyping of liver cancers with prognostic application. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6546-8
|
| 27 |
Alistair Rice, Armando del Rio Hernandez. The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00952
|
| 28 |
Shuixian Du, Songling Liao, Shousheng Liu, Yongning Xin. TM6SF2 E167K Variant Overexpression Promotes Expression of Inflammatory Cytokines in the HCC Cell Line HEPA 1-6. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00055
|
| 29 |
Sayed Sartaj Sohrab, Riya Raj, Amka Nagar, Susan Hawthorne, Ana Cláudia Paiva-Santos, Mohammad Amjad Kamal, Mai M. El-Daly, Esam I. Azhar, Ankur Sharma. Chronic Inflammation’s Transformation to Cancer: A Nanotherapeutic Paradigm. Molecules 2023; 28(11): 4413 doi: 10.3390/molecules28114413
|
| 30 |
Yi Quan, Jun Yang, Tao Qin, Yufang Hu. Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysis. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1748-8
|
| 31 |
Sun Jo Kim, Cheol Woon Jung, Nguyen Hoang Anh, Young Cheol Yoon, Nguyen Phuoc Long, Soon-Sun Hong, Eun Ju Cho, Sung Won Kwon. Metabolic phenotyping combined with transcriptomics metadata fortifies the diagnosis of early-stage Hepatocellular carcinoma. Journal of Advanced Research 2024; doi: 10.1016/j.jare.2024.09.007
|
| 32 |
Linlin Jiang, Qin Meng, Lixiu Liu, Weihang Li. A Comprehensive Review on Molecular Mechanisms, Treatments, and Brief Role of Natural Products in Hepatocellular Cancer. Natural Product Communications 2024; 19(9) doi: 10.1177/1934578X241284873
|
| 33 |
|
| 34 |
Daniele Fanale, Lidia Rita Corsini, Raimondo Scalia, Chiara Brando, Alessandra Cucinella, Giorgio Madonia, Alessandra Dimino, Clarissa Filorizzo, Nadia Barraco, Marco Bono, Alessia Fiorino, Luigi Magrin, Roberta Sciacchitano, Alessandro Perez, Tancredi Didier Bazan Russo, Gianni Pantuso, Antonio Russo, Viviana Bazan. Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?. Critical Reviews in Oncology/Hematology 2022; 170: 103597 doi: 10.1016/j.critrevonc.2022.103597
|
| 35 |
Srinivas Reddy Pallerla, Nghiem Xuan Hoan, Sivaramakrishna Rachakonda, Christian G. Meyer, Hoang Van Tong, Nguyen Linh Toan, Le Thi Kieu Linh, Dao Phuong Giang, Peter G. Kremsner, Mai Hong Bang, Le Huu Song, Thirumalaisamy P. Velavan. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01386-7
|
| 36 |
Celia Sequera, Sara Manzano, Carmen Guerrero, Almudena Porras. How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma. Hepatic Oncology 2018; 5(1) doi: 10.2217/hep-2017-0026
|
| 37 |
Flavio Milana, Michela Anna Polidoro, Simone Famularo, Ana Lleo, Renzo Boldorini, Matteo Donadon, Guido Torzilli. Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence. Cancers 2023; 15(2): 508 doi: 10.3390/cancers15020508
|
| 38 |
Young Hoon Jung, Yun Ji Lee, Tam Dao, Kyung Hee Jung, Junjie Yu, Ah-Reum Oh, Yelin Jeong, HyunJoon Gi, Young Un Kim, Dongryeol Ryu, Michele Carrer, Utpal B. Pajvani, Sang Bae Lee, Soon-Sun Hong, KyeongJin Kim. KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression. Clinical and Molecular Hepatology 2024; 30(4): 895 doi: 10.3350/cmh.2024.0364
|
| 39 |
Bin Xi, Fang-Zhou Luo, Bin He, Fang Wang, Ze-Kuan Li, Ming-Chun Lai, Shu-Sen Zheng. High nuclear ABCG1 expression is a poor predictor for hepatocellular carcinoma patient survival. Hepatobiliary & Pancreatic Diseases International 2022; 21(4): 370 doi: 10.1016/j.hbpd.2022.06.009
|
| 40 |
Jinpo Wang, Rongfeng Huang, Yuehong Huang, Yunxin Chen, Fenglin Chen. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis. Advances in Therapy 2021; 38(6): 3342 doi: 10.1007/s12325-021-01762-2
|
| 41 |
AA Mohamed, D Omran, S El-Feky, H Darwish, AEL Kassas, A Farouk, O Ezzat, SM Abdo, FE Zahran, A El-Demery, MM Omran. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index. British Journal of Biomedical Science 2021; 78(1): 18 doi: 10.1080/09674845.2020.1778842
|
| 42 |
Yajie Wang, Hua Sun, Zhiyan Xiao, Dan Zhang, Xiuqi Bao, Ning Wei. XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10577-7
|
| 43 |
Wen-Yong Wu, Si-Qi Tao, Xiao-Nan Wang, Peter E Lobie, Zheng-Sheng Wu. XIAP 3′-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinoma. Tumor Biology 2017; 39(7): 101042831771957 doi: 10.1177/1010428317719578
|
| 44 |
Enakshi Sivasudhan, Neil Blake, Zhi-Liang Lu, Jia Meng, Rong Rong. Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.642443
|
| 45 |
Ata Moghimi, Nasrin Bani Hosseinian, Mahdi Mahdipour, Ehsan Ahmadpour, Alberto Miranda‐Bedate, Saeid Ghorbian. Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis. Cancer Reports 2024; 7(8) doi: 10.1002/cnr2.2152
|
| 46 |
Guangyi Chen, Zhi-Ping Liu. Inferring causal gene regulatory network via GreyNet: From dynamic grey association to causation. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.954610
|
| 47 |
Pattapon Kunadirek, Natthaya Chuaypen, Piroon Jenjaroenpun, Thidathip Wongsurawat, Nutcha Pinjaroen, Pongserath Sirichindakul, Intawat Nookaew, Pisit Tangkijvanich. Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in Thailand. Cancers 2021; 13(9): 2229 doi: 10.3390/cancers13092229
|
| 48 |
Lifeng He, Xiaoxiao Fan, Yirun Li, Mingming Chen, Bin Cui, Guoqiao Chen, Yili Dai, Daizhan Zhou, Xiaotong Hu, Hui Lin. Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma. Cell Death & Disease 2019; 10(6) doi: 10.1038/s41419-019-1681-3
|
| 49 |
Yongfu Xiong, Gang Yang, Kang Wang, Muhammad Riaz, Jian Xu, Zhenbing Lv, He Zhou, Qiang Li, Weinan Li, Ji Sun, Tang Tao, Jingdong Li. Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00879
|
| 50 |
Haojun Xiong, Yan Zhang, Shan Chen, Zhenhong Ni, Jintao He, Xinzhe Li, Bo Li, Kai Zhao, Fan Yang, Yijun Zeng, Bingbo Chen, Fengtian He. Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells. Oncotarget 2017; 8(38): 64083 doi: 10.18632/oncotarget.19321
|
| 51 |
Hyun-Soo Kim, Joon-Sup Yoon, Yoon Jeon, Eun-Ji Park, Jin-Kwan Lee, Si Chen, Ho Lee, Jee Young Park, Heounjeong Go, Chang-Woo Lee. Ssu72-HNF4α signaling axis classify the transition from steatohepatitis to hepatocellular carcinoma. Cell Death & Differentiation 2022; 29(3): 600 doi: 10.1038/s41418-021-00877-x
|
| 52 |
Malik Siddique Mahmood, Maryam Afzal, Hina Batool, Amara Saif, Tahreem Aqdas, Naeem Mahmood Ashraf, Mahjabeen Saleem. Screening of Pathogenic Missense Single Nucleotide Variants From LHPP Gene Associated With the Hepatocellular Carcinoma: An In silico Approach. Bioinformatics and Biology Insights 2022; 16 doi: 10.1177/11779322221115547
|
| 53 |
Zhenyu Zhang, Jinfeng Zhu, Yansong Huang, Weibing Li, Hongqiu Cheng. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway. Diagnostic Pathology 2018; 13(1) doi: 10.1186/s13000-018-0763-3
|
| 54 |
Konstantinos Arvanitakis, Ioannis Mitroulis, Georgios Germanidis. Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy. Cancers 2021; 13(12): 2899 doi: 10.3390/cancers13122899
|
| 55 |
Chaimaa Zerrad, Mustapha Lkhider, Meryem Bouqdayr, Abdelkader Belkouchi, Wafaa Badre, Mohamed Tahiri, Pascal Pineau, Soumaya Benjelloun, Sayeh Ezzikouri. NOD1 and NOD2 genetic variants: Impact on hepatocellular carcinoma susceptibility and progression in Moroccan population. Gene 2024; 931: 148847 doi: 10.1016/j.gene.2024.148847
|
| 56 |
Yaqian Niu, Fang Liu, Xiuyue Wang, Yuling Chang, Yanmei Song, Huiyuan Chu, Shisan Bao, Che Chen. miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic Glycolysis. OncoTargets and Therapy 2021; : 3649 doi: 10.2147/OTT.S304117
|
| 57 |
Korosh Morshedi, Sarina Borran, Mohammad Saeid Ebrahimi, Mohammad Jaber Masoud khooy, Zeynab Sadat Seyedi, Atefeh Amiri, Mohammad Abbasi‐Kolli, Maryam Fallah, Haroon Khan, Amirhossein Sahebkar, Hamed Mirzaei. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review. Phytotherapy Research 2021; 35(9): 4834 doi: 10.1002/ptr.7119
|
| 58 |
Aroosha Raja, Farhan Haq. Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications. Journal of Cancer Research and Clinical Oncology 2022; 148(1): 15 doi: 10.1007/s00432-021-03826-w
|
| 59 |
Guiming Hu, Fei Gao, Guanzhe Wang, Yan Fang, Yuanyuan Guo, Jun Zhou, Yuhan Gu, Cunzhen Zhang, Na Gao, Qiang Wen, Hailing Qiao. Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-03038-3
|
| 60 |
Nazanin Hosseinkhan, Zahra Narimani, Nastaran Masoudi-Khoram, Mohammad E. Khamseh. The higher body mass index is associated with a lower somatic mutation dependency in hepatocellular carcinoma. Informatics in Medicine Unlocked 2023; 37: 101187 doi: 10.1016/j.imu.2023.101187
|
| 61 |
Fanyun Kong, Delong Kong, Xiaoying Yang, Dongchen Yuan, Ning Zhang, Xuan Hua, Hongjuan You, Kuiyang Zheng, Renxian Tang. Integrative analysis of highly mutated genes in hepatitis B virus‐related hepatic carcinoma. Cancer Medicine 2020; 9(7): 2462 doi: 10.1002/cam4.2903
|
| 62 |
Alexandru Blidisel, Iasmina Marcovici, Dorina Coricovac, Florin Hut, Cristina Adriana Dehelean, Octavian Marius Cretu. Experimental Models of Hepatocellular Carcinoma—A Preclinical Perspective. Cancers 2021; 13(15): 3651 doi: 10.3390/cancers13153651
|
| 63 |
Dan Chen, Xiaoting Li, Hui Li, Kai Wang, Xianghua Tian, Jimei Wang. Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5313149
|
| 64 |
Eman H. Yousef, Mohamed E El-Mesery, Maha R Habeeb, Laila A Eissa. Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma. Tumor Biology 2020; 42(4): 101042832091447 doi: 10.1177/1010428320914475
|
| 65 |
Tengfei Si, Zhenlin Huang, Yuanhang Jiang, Abigail Walker-Jacobs, Shaqira Gill, Robert Hegarty, Mohammad Hamza, Shirin Elizabeth Khorsandi, Wayel Jassem, Nigel Heaton, Yun Ma. Expression Levels of Three Key Genes CCNB1, CDC20, and CENPF in HCC Are Associated With Antitumor Immunity. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.738841
|
| 66 |
Taiji Yamazoe, Taizo Mori, Sachiyo Yoshio, Tatsuya Kanto. Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeutics. Global Health & Medicine 2020; 2(5): 273 doi: 10.35772/ghm.2020.01089
|
| 67 |
淑文 李. The Relationship between the Grade of Hepatocellular Carcinoma and Arterial Blood Supply. Journal of Clinical Personalized Medicine 2024; 3(01): 129 doi: 10.12677/jcpm.2024.31020
|
| 68 |
Ming-Chin Yu, Chao-Wei Lee, Yun-Shien Lee, Jang-Hau Lian, Chia-Lung Tsai, Yi-Ping Liu, Chun-Hsing Wu, Chi-Neu Tsai. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data. World Journal of Gastroenterology 2017; 23(44): 7818-7829 doi: 10.3748/wjg.v23.i44.7818
|
| 69 |
Xing Liu, Aileen Baecker, Ming Wu, Jin‐Yi Zhou, Jie Yang, Ren‐Qiang Han, Pei‐Hua Wang, Zi‐Yi Jin, Ai‐Min Liu, Xiaoping Gu, Xiao‐Feng Zhang, Xu‐Shan Wang, Ming Su, Xu Hu, Zheng Sun, Gang Li, Alan Fu, Su Yon Jung, Lina Mu, Na He, Liming Li, Jin‐Kou Zhao, Zuo‐Feng Zhang. Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population. Liver International 2019; 39(8): 1490 doi: 10.1111/liv.14182
|
| 70 |
Sofia Marka, Maria-Eleftheria Zografaki, Georgia Tsolomiti, Katerina I. Kalliampakou, Athanasios Tsolomitis, Christina Koumantou, Despina Smirlis, Niki Vassilaki, Spyros Kintzios. 2-(4-Nitrophenyl)isothiazol-3(2H)-one: A Promising Selective Agent against Hepatocellular Carcinoma Cells. Pharmaceuticals 2024; 17(6): 673 doi: 10.3390/ph17060673
|
| 71 |
Yanmeng Li, Anjian Xu, Siyu Jia, Jian Huang. Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma (Review). Oncology Letters 2019; doi: 10.3892/ol.2019.10127
|
| 72 |
Syifaus Shodry, Yuliono Trika Nur Hasan, Iwal Reza Ahdi, Zulvikar Syambani Ulhaq. Gene targets with therapeutic potential in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(12): 4543-4547 doi: 10.4251/wjgo.v16.i12.4543
|
| 73 |
Lorenza Rimassa, Maria Reig, Giovanni Abbadessa, Markus Peck-Radosavljevic, William Harris, Vittorina Zagonel, Davide Pastorelli, Elena Rota Caremoli, Camillo Porta, Nevena Damjanov, Hitendra Patel, Bruno Daniele, Maria Lamar, Brian Schwartz, Terri Goldberg, Armando Santoro, Jordi Bruix. Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(13): 2448-2452 doi: 10.3748/wjg.v23.i13.2448
|
| 74 |
Xiaozhong Huang, Fan Lee, Yao Teng, Corey Bryen Lingam, Zijian Chen, Min Sun, Ziwei Song, Gowri M. Balachander, Hwa Liang Leo, Qiongyu Guo, Imran Shah, Hanry Yu. Sequential drug delivery for liver diseases. Advanced Drug Delivery Reviews 2019; : 72 doi: 10.1016/j.addr.2019.11.001
|
| 75 |
Nadia O. M. Mangoud, Sahar A. Ali, Mohamed El Kassas, Sameh H. Soror. Chitinase 3‐like‐1, Tolloid‐like protein 1, and intergenic gene polymorphisms are predictors for hepatocellular carcinoma development after hepatitis C virus eradication by direct‐acting antivirals. IUBMB Life 2021; 73(2): 474 doi: 10.1002/iub.2444
|
| 76 |
Salvatore Gruttadauria, Floriana Barbera, Pier Giulio Conaldi, Duilio Pagano, Rosa Liotta, Enrico Gringeri, Roberto Miraglia, Gaetano Burgio, Marco Barbara, Giada Pietrosi, Calogero Cammà, Fabrizio Di Francesco. Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection. Cancers 2021; 13(3): 518 doi: 10.3390/cancers13030518
|
| 77 |
Robert Eferl, Michael Trauner. Chromosomal instability in HCC: a key function for checkpoint kinase 2. Gut 2018; 67(2): 204 doi: 10.1136/gutjnl-2017-314101
|
| 78 |
Ramesh C. Kovi, Sachin Bhusari, Deepak Mav, Ruchir R. Shah, Thai Vu Ton, Mark J. Hoenerhoff, Robert C. Sills, Arun R. Pandiri. Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice. Archives of Toxicology 2019; 93(8): 2219 doi: 10.1007/s00204-019-02505-7
|
| 79 |
Jui-Hsiang Hung, Chiao-Feng Teng, Hsu-chin Hung, Yi-Lin Chen, Pin-Jun Chen, Chung-Liang Ho, Cheng-Hsiang Chuang, Wenya Huang. Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies. Annals of Hepatology 2024; 29(6): 101546 doi: 10.1016/j.aohep.2024.101546
|
| 80 |
Gui Wang, Yamei Qiao, Yunyan Zhao, Yuanyuan Song, Mengyang Li, Min Jin, Dong Yang, Jing Yin, Junwen Li, Weili Liu. Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosis. Archives of Biochemistry and Biophysics 2023; 745: 109720 doi: 10.1016/j.abb.2023.109720
|
| 81 |
Clara T. Nicolas, Caitlin J. VanLith, Raymond D. Hickey, Zeji Du, Lori G. Hillin, Rebekah M. Guthman, William J. Cao, Benjamin Haugo, Annika Lillegard, Diya Roy, Aditya Bhagwate, Daniel O’Brien, Jean-Pierre Kocher, Robert A. Kaiser, Stephen J. Russell, Joseph B. Lillegard. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-32576-7
|
| 82 |
Gustavo dos Santos Fernandes, Daniel Campos, Andre Ballalai, Rodrigo Palhares, Mario R. A. da Silva, Daniel M. F. Palhares, Ben-Hur F. Neto, Fabio M. do R. Barros, Roberto de A. Gil, Aline Chagas, Flair José Carrilho. Epidemiological and Clinical Patterns of Newly Diagnosed Hepatocellular Carcinoma in Brazil: the Need for Liver Disease Screening Programs Based on Real-World Data. Journal of Gastrointestinal Cancer 2021; 52(3): 952 doi: 10.1007/s12029-020-00508-7
|
| 83 |
Hao Cheng, Yiming Pan, Yongzhong Yao, Zhanghua Zhu, Jun Chen, Xitai Sun, Yudong Qiu, Yitao Ding. Expression and significance of caveolin‑1 in hepatitis B virus‑associated hepatocellular carcinoma. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5038
|
| 84 |
Hala Mosaad, Emad A. Emam, Emad F. Hamed, Ezzat A. El Demerdash, Samia Hussein. Vitamin D receptor gene polymorphism and hepatocellular carcinoma in chronic hepatitis C patients. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00063-7
|
| 85 |
Shan Huang, Da Zhou, Yu‐Xuan Li, Zhi‐Yong Ming, Ke‐Zhi Li, Guo‐Bin Wu, Chuang Chen, Yin‐Nong Zhao. Retracted: In vivo and in vitro effects of microRNA‐221 on hepatocellular carcinoma development and progression through the JAK–STAT3 signaling pathway by targeting SOCS3. Journal of Cellular Physiology 2019; 234(4): 3500 doi: 10.1002/jcp.26863
|
| 86 |
Harpreet Kaur, Sherry Bhalla, Gajendra P. S. Raghava, Ernest K. Amankwah. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles. PLOS ONE 2019; 14(9): e0221476 doi: 10.1371/journal.pone.0221476
|
| 87 |
Elissaios A. Kontis. Anesthesia for Hepatico-Pancreatic-Biliary Surgery and Transplantation. 2021; : 303 doi: 10.1007/978-3-030-51331-3_18
|
| 88 |
Xiao-Xiao Ding, Qing-Ge Zhu, Shi-Ming Zhang, Lei Guan, Ting Li, Lei Zhang, Shi-Yang Wang, Wan-Li Ren, Xue-Mei Chen, Jing Zhao, Song Lin, Zhi-Zhen Liu, Yan-Xia Bai, Bing He, Hu-Qin Zhang. Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy. Oncotarget 2017; 8(33): 55715 doi: 10.18632/oncotarget.18382
|
| 89 |
Yun Zeng, Zhengjie Shen, Wenzhe Gu, Mianhua Wu. Inhibition of hepatocellular carcinoma tumorigenesis by curcumin may be associated with CDKN1A and CTGF. Gene 2018; 651: 183 doi: 10.1016/j.gene.2018.01.083
|
| 90 |
Samy Azer. MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?. Journal of Clinical Medicine 2018; 7(4): 64 doi: 10.3390/jcm7040064
|
| 91 |
Di-yang Xie, Hong-kai Fan, Zheng-gang Ren, Jia Fan, Qiang Gao. Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications. Clinical and Translational Gastroenterology 2019; 10(2): e00006 doi: 10.14309/ctg.0000000000000006
|
| 92 |
Elisa Holstein, Mathias Binder, Wolfgang Mikulits. Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics. International Journal of Molecular Sciences 2018; 19(12): 4111 doi: 10.3390/ijms19124111
|
| 93 |
Idy C.‐Y. Leung, Charing C.‐N. Chong, Tan T. Cheung, Philip C. Yeung, Kelvin K.‐C. Ng, Paul B.‐S. Lai, Stephen L. Chan, Anthony W.‐H. Chan, Patrick M.‐K. Tang, Siu T. Cheung. Genetic variation in ABCB5 associates with risk of hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2020; 24(18): 10705 doi: 10.1111/jcmm.15691
|
| 94 |
Young-Joo Jin, Seyoun Byun, Seonggyun Han, John Chamberlin, Dongwook Kim, Min Jung Kim, Younghee Lee. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors. BMC Medical Genomics 2019; 12(S8) doi: 10.1186/s12920-019-0635-z
|
| 95 |
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759
|
| 96 |
Han-Yu Jiang, Jie Chen, Chun-Chao Xia, Li-Kun Cao, Ting Duan, Bin Song. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. World Journal of Gastroenterology 2018; 24(22): 2348-2362 doi: 10.3748/wjg.v24.i22.2348
|
| 97 |
Qiang Yu, Xia Yang, Weidong Duan, Chonghui Li, Ying Luo, Shichun Lu. miRNA-346 promotes proliferation, migration and invasion in liver cancer. Oncology Letters 2017; 14(3): 3255 doi: 10.3892/ol.2017.6561
|
| 98 |
Liyuan Hao, Shenghao Li, Guo Chen, Aiyu Nie, Liang Zeng, Zhonghui Xiao, Xiaoyu Hu. Study on the mechanism of quercetin in Sini Decoction Plus Ginseng Soup to inhibit liver cancer and HBV virus replication through CDK1. Chemical Biology & Drug Design 2024; 103(6) doi: 10.1111/cbdd.14567
|
| 99 |
Yingxue Lin, Yinhui Yao, Ying Wang, Lingdi Wang, Haipeng Cui, Tao Huang. PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular Carcinoma. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5516100
|
| 100 |
Tao Wang, Zhiyuan Shao, Yifu Xiao, Xuchao Zhang, Yitian Chen, Binze Shi, Siyu Chen, Yuxian Wang, Jiajie Peng, Xuequn Shang. Predicting Hepatoma-Related Genes Based on Representation Learning of PPI network and Gene Ontology Annotations. 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2021; : 1892 doi: 10.1109/BIBM52615.2021.9669479
|
| 101 |
Keisaku Sato, Fanyin Meng, Heather Francis, Nan Wu, Lixian Chen, Lindsey Kennedy, Tianhao Zhou, Antonio Franchitto, Paolo Onori, Eugenio Gaudio, Shannon Glaser, Gianfranco Alpini. Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies. Journal of Pineal Research 2020; 68(3) doi: 10.1111/jpi.12639
|
| 102 |
Rodrigo Carlessi, Julia Köhn-Gaone, John K. Olynyk, Janina E. E. Tirnitz-Parker. Hepatocellular Carcinoma. 2019; : 69 doi: 10.15586/hepatocellularcarcinoma.2019.ch4
|
| 103 |
Yoshihiro Shioi, Mitsumasa Osakabe, Naoki Yanagawa, Hiroyuki Nitta, Akira Sasaki, Tamotsu Sugai. Analysis of Somatic Copy Number Alterations in Biliary Tract Carcinoma Using a Single Nucleotide Polymorphism Array. Future Science OA 2022; 8(1) doi: 10.2144/fsoa-2021-0057
|
| 104 |
Ye-Bin Lu, Qin Jiang, Man-Yi Yang, Ji-Xiang Zhou, Qi Zhang. Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis. Oncotarget 2017; 8(51): 88804 doi: 10.18632/oncotarget.21321
|
| 105 |
Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 1279 doi: 10.2147/JHC.S392051
|
| 106 |
Lin Li, Yun-Feng Zhou, Yan-Lin Li, Li-Li Wang, Hiderori Arai, Yang Xu. <i>In vitro</i> and <i>in vivo</i> antioxidative and hepatoprotective activity of aqueous extract of Cortex Dictamni. World Journal of Gastroenterology 2017; 23(16): 2912-2927 doi: 10.3748/wjg.v23.i16.2912
|
| 107 |
Yali Liu, Wuyi Liu, Jingbin Huang, Wenjing Lai, Faning Leng, Changpeng Hu, Qian Zhang, Min Zhou, Qin Tang, Fangfang Sheng, Guobing Li, Rong Zhang.
Cu
2-x
Se Nanoparticles Enhance the Anticancer Activity of Oxaliplatin By Inhibiting Autophagic Degradation
. Nanomedicine 2019; 14(10): 1307 doi: 10.2217/nnm-2018-0284
|
| 108 |
Cristina Enríquez-Cortina, Oscar Bello-Monroy, Patricia Rosales-Cruz, Verónica Souza, Roxana U. Miranda, Rafael Toledo-Pérez, Armando Luna-López, Arturo Simoni-Nieves, Rogelio Hernández-Pando, María Concepción Gutiérrez-Ruiz, Diego F. Calvisi, Jens U. Marquardt, Leticia Bucio, Luis Enrique Gomez-Quiroz. Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis. Oncotarget 2017; 8(61): 104136 doi: 10.18632/oncotarget.22024
|
| 109 |
Yang Ge, Pengfei Gu, Wenbo Wang, Liyuan Cao, Lulu Zhang, Jingquan Li, Wei Mu, Hui Wang, Wei-Ping Jia. Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascades. Journal of Molecular Cell Biology 2021; doi: 10.1093/jmcb/mjab052
|
| 110 |
Maen Abdelrahim, Ali Alqahtani, Abdullah Esmail, Bandar Al-Judaibi. Transplant Oncology. 2025; : 277 doi: 10.1016/B978-0-443-21901-6.00024-0
|